| Date Filed | Type | Description |
| 10/10/2023 |
4
| Walsh John F (COO) has filed a Form 4 on Accenture plc|
Txns:
| Granted 90 shares
@ $307.89, valued at
$27.7k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/23/2020 |
4
| Walsh John F (Grp Chief Exec-Com, Med & Tech) has filed a Form 4 on Accenture plc|
Txns:
| Sold 166 shares
@ $208.3247, valued at
$34.6k
Sold 4,971 shares
@ $209.1415, valued at
$1M
Sold 863 shares
@ $209.7833, valued at
$181k
|
|
| 01/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2019 |
4
| Walsh John F (Grp Chief Exec-Com, Med & Tech) has filed a Form 4 on Accenture plc|
Txns:
| Granted 909 shares
@ $199.455, valued at
$181.3k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/06/2019 |
4
| Walsh John F (Grp Chief Exec-Com, Med & Tech) has filed a Form 4 on Accenture plc|
Txns:
| Granted 112 shares
@ $186.74, valued at
$20.9k
|
|
| 11/06/2019 |
3
| Walsh John F (Grp Chief Exec-Com, Med & Tech) has filed a Form 3 on Accenture plc |